Section 1: Hero

Junbell® is a consumer accessibility app, employing technology that turns familiar music and simple, structured interaction into a practical way to communicate when spoken words are no longer easy. Built from lived experience and refined through early use by families, it is designed to complement existing communication methods and to work alongside speech pathologists in Melbourne, Manila, and beyond.If you or someone you love is navigating life after stroke, dysarthria, or another acquired speech disorder, you are not alone. Many families are looking for tools that feel human, affordable, and usable in real daily moments. Whether for use at home, at work, and in public, Junbell® was created for those moments.Learn more about the research, the stories, and the clinical partnerships shaping what comes next.For Speech Pathologists
Learn Jun's & Gerald's Stories

Section 2: Important Notice

⚠️ Important NoticeJunbell® is a consumer accessibility application designed to complement existing communication methods. It is not intended to replace professional speech therapy, medical treatment, or prescribed AAC devices.We work with speech pathologists because communication after stroke is clinical, personal, and highly individual. Our goal is to support families with an additional option, but never to stand in place of evidence-based care.

Section 3: Jun's Story

The Story Behind Junbell®From Friendship to InnovationJun was not only a best friend. He was a guitarist who never gave up.Born with debilitating polio, he walked with a limp his entire life. But he never allowed it to define the limits of what he could do. Music was the thread that ran through our friendship. In our university days, we tried to form a band; Jun’s guitar became both his voice and the instrument to express his passion.Then came the fateful day in March 2025. A stroke affected Jun’s speech and his ability to communicate with his spouse and their three children. Watching a close friend struggle to express even simple needs was heartbreaking. He turned to knocking and gestures. Those methods were functional, but they were also limiting and, at times, deeply frustrating, especially when something specific needed to be said.On 11 September 2025, while humming “While My Guitar Gently Weeps,” the words shifted in mind: “While my guitar gently speaks.”That was the moment the question became clear: What if music itself could help people communicate? Music is the universal language. Perhaps there was a way to make music as a medium of assisted communication for those who are experiencing the same condition as Jun? We sought to answer these questions that could benefit a far greater number of people.What began as a solution for one friend quickly revealed a much wider need among stroke survivors and people with acquired speech disorders who want a more natural, music-informed way to be understood.Jun now uses Junbell® and his family actively encourages adoption. They have seen first-hand how the technology can be valuable, particularly during emergencies.Using Junbell® has become his daily practice. Habit change takes time. He is still building the routine. Even so, Jun is increasingly choosing Junbell® over knocking when he needs to communicate something specific.This early validation, including both the successes and the challenges we have faced together, is the reason clinical research is happening before any wider launch. Teaching a new communication system is not a one-tap solution. Families succeed when several things are present:
• Structured daily practice
• Family encouragement and participation
• Patient motivation and time to form new habits
• Clinical support for thoughtful implementation
That is why Junbell® is building relationships with speech pathologists in Melbourne and Manila: to learn what works, what does not, and how to help families use the tool with greater confidence.These early stories are only the beginning. They point toward a larger question many families are already asking: how do we give people their voice back in a way that feels like them?

Gerald's Story




Getting Back Behind the WheelJun's story is where Junbell® began. Gerald's story shows where it's going.Gerald Guevara is a 34-year-old cab driver from Cebu who experienced a stroke in August 2024. He lives with dysarthria and dysphagia. These are muscular motor and swallowing disorders that affect the area used for speech, but not the brain’s ability to understand or form language.He can understand everything. He can read and type. He now uses Junbell® to communicate verbally.“Pero pag nakilala mo ang panginoon everything will be fine.”- Gerald
(But when you know the Lord, everything will be fine.)
After months of depression and frustration from his condition, Gerald found Junbell®. He is now testing Junbell® 4 (Bisaya version) with the JunType keyboard and JunReady, using it with family and others as he prepares to return to his cab.“Mas naging easier yung communication ko sa mga kasama ko sa bahay.”
(Communication with my housemates has become much easier.) — January 2026
Gerald represents millions of younger stroke survivors who need affordable communication tools for real-world life: work, mobility, ordering food, correcting a mistake, being understood without someone speaking for them.He has used Junbell® to order food on his own at a fast-food counter. No one speaking for him and no one translating. It is a small everyday moment most people never think twice about. It is also exactly the kind of independence Junbell® exists to help restore.In June 2026, Gerald used Junbell® entirely on his own. There were no family members, nor any clinician nearby. This event was to sort out a mix-up at a local eatery where he had been shortchanged. In his own words: “buti nlng may Junbell® na explain ko”( “good thing I had Junbell® to explain it).”That is not a controlled demonstration. That is daily life. A situation anyone with Gerald’s similar condition might encounter. And Junbell® helped him get through it on his own. How many more could benefit from this technology?Currently testing: Junbell® 4
Stroke date: August 2024 (17 months post-stroke)
Location: Cebu, Philippines
Stories like Jun’s and Gerald’s are why this work continues. Progress is made carefully, clinically, and with their families at the centre. And it is to their credit that their experiences continue to guide how we build and refine Junbell®.If you are a speech pathologist, a family member, or someone living with an acquired speech disorder, there is more to explore: how music-based communication can sit alongside therapy, how early users are building new habits, and how this initiative is growing through research rather than hype.


Section 4: Clinical Foundation

Why the Foundation of Musical Communication WorksAfter a left-hemisphere stroke, many survivors lose spoken language but keep a surprising capacity for music. Research shows musical processing is often spared even when speech is severely impaired. [1]That same observation underpins Melodic Intonation Therapy (MIT), a well-established speech-pathology approach that uses melody and rhythm to help people with aphasia work toward producing speech. [2]Junbell® starts from that insight then applies it differently.MIT is therapy: it helps someone rebuild speech over time. Junbell is communication: a learned musical pattern retrieves and speaks a stored everyday phrase. The goal is immediate and applicable with functional conversation such as ordering food, calling for help, saying a name. While this is not direct speech rehabilitation, the applications are still very practical and addresses multiple needs.Jun’s experience after strokeJun had a stroke in March 2025 and is unable to speak. He can still recognise melodies, distinguish musical notes, and use a tablet keyboard to produce musical patterns. His guitar playing has not yet returned, but his musical processing remains intact. That preserved pathway is what Junbell is designed to use.How Junbell applies the science• A small, simple set of notes — not a complex new vocabulary
• Musical patterns built to become easy to remember with practice
• Relies on brain pathways that are often spared after left-hemisphere stroke
• Faster potential uptake than sign language for many users (days to weeks, not months)
• Not limited to aphasia — also showing value in other acquired speech disorders, including dysarthria, where the challenge is producing speech rather than understanding or forming language
Designed for the questions clinicians actually askResearchers in stroke rehabilitation and music neuroscience have asked the right hard questions: What if someone cannot process music after their stroke? What if a new system overloads memory that is already working hard to recover? What is the fastest path when someone needs to say something right now?Those questions are why Junbell is not only the musical system. JunType and JunReady mean no one has to learn music before they can start communicating.


Research References:
[1] Särkämö et al. (2008). "Music listening enhances cognitive recovery and mood after middle cerebral artery stroke." Brain, 131(3), 866-876.

[2] Norton et al. (2009). "Melodic Intonation Therapy: Shared Insights on How It Is Done and Why It Might Help." Annals of the New York Academy of Sciences, 1169, 431-436.

Section 5: Current Phase

Current Phase: Building the Evidence Base, One Relationship at a TimeWe're Doing This Right, Not FastThe AAC device industry has a 60-70% abandonment rate within the first
year.[4] We refuse to add to this problem.
Where things stand:• Jun and Gerald continue to use Junbell in real life — Jun for emergencies at home in Manila, Gerald daily in Cebu, including sorting out everyday situations completely on his own.
• A/Prof Jeanette Tamplin, Head of Music Therapy at the University of Melbourne, has provided a formal letter of support describing Junbell as addressing "a gap in clinical service provision" with "potential for commercialisation and dissemination on a global scale."
• We're preparing for our first in-person clinical demonstration with speech pathology leaders from the University of Melbourne and Austin Health.
• TechDiversity Merit Award Recipient (2026)
• Startup Daily Best in Tech Awards 2026 Finalist
What we're still learning:
• Whether Junbell works as well for people without a musical background as it does for those with one.
• What training and support helps families build the habit of using it.
• Which patient profiles benefit most, and what level of hand function is needed.
Public Launch: 2026 (TBA)
2026 (TBA) — with clinical input, real-world evidence, and training materials families can actually use.
We're not rushing to market—we're building something families will
actually use long-term.
---Research References:
[4] Johnson et al. (2006). "Factors that influence the use of AAC: A review
of the literature." Journal of Medical Speech-Language Pathology, 14(1),
9-27.

Section 6: For Speech Pathologists - Design Partner Program

Join Our Clinical Design Partner ProgramWe're Not Looking for Beta TestersWe're seeking 3 Melbourne & Manila speech pathologists to become Clinical Design
Partners
—active collaborators who shape Junbell's clinical features.

What Design Partners Do:
✓ Test with 5 patients from your caseload (with consent)
✓ Shape clinical training materials based on real feedback
✓ Influence which features matter most to SLPs
✓ Co-author research case studies for publication
What You Receive:
- Free MIDI keyboard devices ($120 value each)
- Free software access during pilot
- Co-authorship on published case studies
- Listed as "Founding Clinical Partner" on our website
- First access to commercial partnerships
- Your insights directly shape the product
Time Commitment:
- 30-minute initial call
- 15-minute weekly check-ins (phone/email)
- One 60-minute debrief after pilot
- Total: ~5-7 hours over 3 months

Why Partner With Us:✓ Clinical Credibility: Founder is ISAAC Australia and AGOSCI member—
we're building WITH the AAC community, not disrupting from outside
✓ Real User Validation: Gerald uses Junbell daily, and Jun's family is actively building the habit with him—this works, we're refining how to scale it✓ Research Opportunities: Pilot findings submitted to International
Journal of Speech-Language Pathology and ISAAC conferences
✓ Solve Real Problems: Address device-dependence frustrations and
high abandonment rates
✓ Filipino-Australian Community: Direct access to underserved
population seeking affordable AAC solutions
Current Status:
Current Status: Building our clinical partner network for 2026–2027. If you're a speech pathologist or music therapist curious about Junbell, we'd love to hear from you.
Ideal Partners:
- Treat stroke survivors with aphasia
- Curious about music therapy and communication approaches
- Based in Melbourne or Manila
- Want to contribute to AAC innovation
"Express Interest in Design Partnership"

Section 7: Professional Credentials

Professional Affiliations


ISAAC Australia Member
International Society for AAC


AGOSCI Member
Australian Group on Severe
Communication Impairment

ARATA Member
(Australian Rehabilitation & Assistive Technology Association)


Poster Presenter — Australian Assistive Technology Conference 2026 (AATC), Melbourne, 11–13 November 2026, hosted by ARATA (Australian Rehabilitation & Assistive Technology Association)

  • TechDiversity Merit Award Recipient (2026)

  • Startup Daily Best in Tech Awards 2026 Finalist

Founder: Julius Caesar "Julz" Maramba"As an ISAAC and AGOSCI member, I'm committed to developing Junbell WITH
AAC professionals, not in isolation. Being part of the community helps
ensure Junbell truly serves those who need it most."
- ISAAC Australia Member
- AGOSCI Member
- 20+ years engineering expertise
- Filipino-Australian entrepreneur

Section 8: Validation & Support

Building Junbell with Industry Recognition

Remarkable Launcher 2026
Selected for Global Disability Tech Pre-Accelerator

Junbell has been selected for Remarkable Launcher 2026, a 12-week
pre-accelerator program for early-stage disability and health tech
startups.
Program Highlights:
✓ Cohort of 42 disability tech startups globally
✓ Masterclasses led by industry experts
✓ One-on-one coaching from Remarkable specialists
✓ March-May 2026 development intensive
✓ Showcase Day: May 26, 2026
Supported by:
Cerebral Palsy Alliance | TPG Telecom Foundation | LaunchVic
What this means:
Independent validation that Junbell addresses real needs in the AAC
and disability tech space. We're building with support from experienced
mentors who understand assistive technology.

TechDiversity Awards 2026 — Merit Award Recipient and Campaign of the Year FinalistJunbell® received a Merit Award at the TechDiversity Awards 2026 Gala Dinner, held at the Sofitel Sydney Wentworth on 31 July 2026. The company was also named a finalist in Campaign of the Year, recognising work that puts diverse voices and lived experience at the centre of technology.The TechDiversity Awards celebrate organisations using diversity, equity, and inclusion to build stronger technology and a more capable Australian tech workforce. In 2026, the program moved to Sydney for the first time under the theme Influence Redefined: Power in Every Voice. Judge Adam O’Donnell said he was “fascinated” by a video of Gerald independently ordering food using Junbell. He described it as a moment that “probably touched everyone on this call”.Startup Daily Best in Tech Awards 2026 — Dual Category FinalistJunbell® is a finalist in two categories at the 2026 Startup Daily Best in Tech Awards:
• Best New Idea
• The AI Gamechanger
The awards drew more than 265 entries from across Australia and New Zealand. Finalists were selected for innovation, measurable impact, and the potential to change how people live and work. The Gala Dinner was held at The Ivy Ballroom in Sydney on 10 September 2026, where the winners were announced.

Academic Research Interest
Building Clinical Validation Pathway
Music therapy and stroke rehabilitation researchers have expressed
interest in potential collaboration on Junbell validation studies.
Potential Research Areas:
✓ Clinical effectiveness with stroke survivors
✓ Ethics-approved testing protocols
✓ Grant-funded validation research
✓ International partnerships
Current Status:
Early discussions in progress. Research collaborations to be formalized
when academic schedules and appropriate funding align.
Why this matters:
Academic research validation would provide evidence-based foundation
for Junbell's effectiveness across diverse stroke survivor populations.

Together:
Industry development (Remarkable) + academic research interest
= commercially viable AND clinically validated solution.

Get In Touch

Contact Information:
Julius Maramba
Email: [email protected]
Phone: +61 439 353 197
Location: Melbourne, Australia


Junbell™. All rights reserved.

Thank You

Thank you for reaching out!We've received your message and will respond within 24 hours.